Canadian Government Not Ordering Novavax’s Protein-Based COVID-19 Vaccine This Year
Vials of freshly manufactured Novavax COVID-19 vaccines wait to be labelled in Pune, India, in 2022. The Canadian Press/AP-HO, Serum Institute of India for Novavax
The Public Health Agency of Canada says it is not providing Novavax’s COVID-19 vaccine this respiratory virus season, citing low demand.
It says the manufacturer requires a minimum order of its updated protein-based vaccine, called Nuvaxovid, which far exceeds the uptake by Canadians last year.
